Tag
Cybin Inc.
- Psychedelic drug developer Cybin secures major financing deal
- Billionaire Steve Cohen's Point 72 hedge fund takes 8.1% stake in Cybin
- Cybin inks agreement to acquire DMT drug developer Small Pharma
- Cybin acquires license for psychedelic molecules from Mindset
- Cybin administers psychedelic analogue to patients with major depression
- Cybin receives Schedule I DEA license for CYB003 trial
- Cybin receives FDA approval for new in‑human clinical trial